Financial Ratios Shanghai MicroPort MedBot (Group) Co., Ltd.
Equities
2252
CNE100004QP1
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.92 HKD | +17.30% |
|
+17.93% | +27.24% |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
Profitability | ||||||
Return on Assets | -11.4 | -15.84 | -29.04 | -33.55 | -22.28 | |
Return on Total Capital | -13.55 | -17.56 | -32.47 | -41.33 | -29.47 | |
Return On Equity % | -28.52 | -30.51 | -60.36 | -107.2 | -170.42 | |
Return on Common Equity | -27.62 | -30.39 | -59.82 | -104.5 | -161.07 | |
Margin Analysis | ||||||
Gross Profit Margin % | - | 42.74 | 30.38 | 14.05 | 33.52 | |
SG&A Margin | - | 8.68K | 1.64K | 348.77 | 102.32 | |
EBITDA Margin % | - | -26.16K | -4.88K | -803.31 | -158.72 | |
EBITA Margin % | - | -26.5K | -5.08K | -861.5 | -187.31 | |
EBIT Margin % | - | -26.5K | -5.08K | -861.67 | -187.54 | |
Income From Continuing Operations Margin % | - | -27.19K | -5.31K | -978.59 | -251.55 | |
Net Income Margin % | - | -27.11K | -5.28K | -967.74 | -249.72 | |
Net Avail. For Common Margin % | - | -27.11K | -5.28K | -967.74 | -249.72 | |
Normalized Net Income Margin | - | -15.74K | -3.29K | -576.59 | -125.13 | |
Levered Free Cash Flow Margin | - | -25.23K | -3.53K | -342.41 | -72.83 | |
Unlevered Free Cash Flow Margin | - | -25.08K | -3.49K | -331.41 | -67.6 | |
Asset Turnover | ||||||
Asset Turnover | - | 0 | 0.01 | 0.06 | 0.19 | |
Fixed Assets Turnover | - | 0.01 | 0.05 | 0.24 | 0.77 | |
Receivables Turnover (Average Receivables) | - | - | - | - | 5.26 | |
Inventory Turnover (Average Inventory) | - | - | 0.08 | 0.37 | 0.9 | |
Short Term Liquidity | ||||||
Current Ratio | 6.62 | 8.93 | 3.38 | 1.16 | 1.7 | |
Quick Ratio | 6.59 | 8.31 | 2.52 | 0.8 | 1.4 | |
Operating Cash Flow to Current Liabilities | -0.45 | -2.31 | -2.76 | -0.83 | -0.59 | |
Days Sales Outstanding (Average Receivables) | - | - | - | - | 69.57 | |
Days Outstanding Inventory (Average Inventory) | - | - | 4.37K | 974.4 | 407.65 | |
Average Days Payable Outstanding | - | - | 244.07 | 526.37 | 306.73 | |
Cash Conversion Cycle (Average Days) | - | - | - | - | 170.49 | |
Long Term Solvency | ||||||
Total Debt/Equity | 1.33 | 8.58 | 15.65 | 118.74 | 268.29 | |
Total Debt / Total Capital | 1.32 | 7.9 | 13.53 | 54.28 | 72.85 | |
LT Debt/Equity | 0.8 | 6.35 | 11.49 | 34.32 | 159.73 | |
Long-Term Debt / Total Capital | 0.79 | 5.85 | 9.93 | 15.69 | 43.37 | |
Total Liabilities / Total Assets | 15.43 | 14.39 | 27.06 | 64.86 | 79.85 | |
EBIT / Interest Expense | -3.31 | -107.62 | -98.6 | -48.96 | -22.43 | |
EBITDA / Interest Expense | -3.22 | -101.03 | -89.71 | -43.03 | -17.2 | |
(EBITDA - Capex) / Interest Expense | -3.52 | -125.78 | -106.63 | -46.56 | -19.14 | |
Total Debt / EBITDA | -0.12 | -0.38 | -0.22 | -0.75 | -1.87 | |
Net Debt / EBITDA | 9.33 | 3.25 | 0.53 | -0.11 | -0.21 | |
Total Debt / (EBITDA - Capex) | -0.11 | -0.31 | -0.19 | -0.7 | -1.68 | |
Net Debt / (EBITDA - Capex) | 8.55 | 2.61 | 0.44 | -0.1 | -0.19 | |
Growth Over Prior Year | ||||||
Total Revenues, 1 Yr. Growth % | - | - | 904.79 | 384.15 | 145.95 | |
Gross Profit, 1 Yr. Growth % | - | - | 614.04 | 123.93 | 486.77 | |
EBITDA, 1 Yr. Growth % | 132.47 | 249.54 | 87.46 | -20.32 | -51.4 | |
EBITA, 1 Yr. Growth % | 131.16 | 250.36 | 92.57 | -17.86 | -46.52 | |
EBIT, 1 Yr. Growth % | 131.16 | 250.36 | 92.57 | -17.84 | -46.47 | |
Earnings From Cont. Operations, 1 Yr. Growth % | 199.84 | 179.28 | 96.11 | -10.71 | -36.78 | |
Net Income, 1 Yr. Growth % | 199.24 | 179.08 | 95.53 | -11.2 | -36.53 | |
Normalized Net Income, 1 Yr. Growth % | 198.88 | 159.53 | 109.79 | -15.06 | -46.62 | |
Diluted EPS Before Extra, 1 Yr. Growth % | 137.91 | 136.01 | 87.63 | -11.2 | -37.08 | |
Accounts Receivable, 1 Yr. Growth % | - | - | - | - | 1.77K | |
Inventory, 1 Yr. Growth % | - | - | 127.95 | -8.37 | -34 | |
Net Property, Plant and Equip., 1 Yr. Growth % | 168.02 | 832.58 | 36.17 | -25.34 | -18.98 | |
Total Assets, 1 Yr. Growth % | 2.07K | 63.81 | -30.87 | -26.02 | -10.43 | |
Tangible Book Value, 1 Yr. Growth % | 5.43K | 65.78 | -41.01 | -63.92 | -46.36 | |
Common Equity, 1 Yr. Growth % | 5.36K | 65.86 | -40.76 | -63.36 | -46.45 | |
Cash From Operations, 1 Yr. Growth % | 111.6 | 424.53 | 66.23 | -36.8 | -47.5 | |
Capital Expenditures, 1 Yr. Growth % | 297.65 | 800.07 | 43.72 | -65.48 | -35.7 | |
Levered Free Cash Flow, 1 Yr. Growth % | - | -1.37K | 40.43 | -52.98 | -47.63 | |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | -832.85 | 40 | -54.08 | -49.78 | |
Compound Annual Growth Rate Over Two Years | ||||||
Total Revenues, 2 Yr. CAGR % | - | - | - | 597.48 | 245.08 | |
Gross Profit, 2 Yr. CAGR % | - | - | - | 299.86 | 262.48 | |
EBITDA, 2 Yr. CAGR % | - | 185.06 | 155.98 | 22.22 | -37.77 | |
EBITA, 2 Yr. CAGR % | - | 184.59 | 159.75 | 25.77 | -33.72 | |
EBIT, 2 Yr. CAGR % | - | 184.59 | 159.75 | 25.78 | -33.68 | |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | 189.38 | 134.03 | 32.33 | -24.87 | |
Net Income, 2 Yr. CAGR % | - | 188.98 | 133.6 | 31.77 | -24.93 | |
Normalized Net Income, 2 Yr. CAGR % | - | 178.51 | 133.34 | 33.5 | -32.67 | |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | 136.96 | 110.43 | 29.08 | -25.25 | |
Accounts Receivable, 2 Yr. CAGR % | - | - | - | 655.74 | - | |
Inventory, 2 Yr. CAGR % | - | - | - | 44.52 | -22.23 | |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | 399.95 | 256.36 | 0.83 | -22.22 | |
Total Assets, 2 Yr. CAGR % | - | 496.61 | 6.42 | -28.48 | -18.6 | |
Tangible Book Value, 2 Yr. CAGR % | - | 857.12 | -1.11 | -53.86 | -56 | |
Common Equity, 2 Yr. CAGR % | - | 851.9 | -0.88 | -53.41 | -55.7 | |
Cash From Operations, 2 Yr. CAGR % | - | 233.15 | 195.29 | 2.5 | -42.4 | |
Capital Expenditures, 2 Yr. CAGR % | - | 498.26 | 259.67 | -29.57 | -52.89 | |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | 321.57 | -18.75 | -50.41 | |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | 220.31 | -19.82 | -52 | |
Compound Annual Growth Rate Over Three Years | ||||||
Total Revenues, 3 Yr. CAGR % | - | - | - | - | 392.76 | |
Gross Profit, 3 Yr. CAGR % | - | - | - | - | 354.39 | |
EBITDA, 3 Yr. CAGR % | - | - | 147.89 | 73.48 | -10.13 | |
EBITA, 3 Yr. CAGR % | - | - | 149.84 | 76.96 | -5.43 | |
EBIT, 3 Yr. CAGR % | - | - | 149.84 | 76.98 | -5.39 | |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | 154.18 | 69.74 | 3.45 | |
Net Income, 3 Yr. CAGR % | - | - | 153.7 | 69.22 | 3.29 | |
Normalized Net Income, 3 Yr. CAGR % | - | - | 153.41 | 66.61 | -1.65 | |
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | 119.22 | 57.84 | 1.59 | |
Accounts Receivable, 3 Yr. CAGR % | - | - | - | - | 921.87 | |
Inventory, 3 Yr. CAGR % | - | - | - | - | 11.3 | |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | 224.07 | 111.65 | -6.26 | |
Total Assets, 3 Yr. CAGR % | - | - | 190.87 | -5.73 | -22.91 | |
Tangible Book Value, 3 Yr. CAGR % | - | - | 278.08 | -29.33 | -51.49 | |
Common Equity, 3 Yr. CAGR % | - | - | 277.22 | -28.86 | -51.2 | |
Cash From Operations, 3 Yr. CAGR % | - | - | 164.24 | 76.63 | -17.99 | |
Capital Expenditures, 3 Yr. CAGR % | - | - | 271.91 | 64.67 | -31.67 | |
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | - | 102.92 | -29.84 | |
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | - | 67.65 | -31.42 | |
Compound Annual Growth Rate Over Five Years | ||||||
EBITDA, 5 Yr. CAGR % | - | - | - | - | 42.61 | |
EBITA, 5 Yr. CAGR % | - | - | - | - | 46.94 | |
EBIT, 5 Yr. CAGR % | - | - | - | - | 46.98 | |
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | - | 56.11 | |
Net Income, 5 Yr. CAGR % | - | - | - | - | 55.88 | |
Normalized Net Income, 5 Yr. CAGR % | - | - | - | - | 49.14 | |
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | - | 42.55 | |
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | - | 83.12 | |
Total Assets, 5 Yr. CAGR % | - | - | - | - | 74.77 | |
Tangible Book Value, 5 Yr. CAGR % | - | - | - | - | 59.92 | |
Common Equity, 5 Yr. CAGR % | - | - | - | - | 60.15 | |
Cash From Operations, 5 Yr. CAGR % | - | - | - | - | 43.67 | |
Capital Expenditures, 5 Yr. CAGR % | - | - | - | - | 62.75 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















